MD4300C1 - Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel - Google Patents
Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickelInfo
- Publication number
- MD4300C1 MD4300C1 MDA20120128A MD20120128A MD4300C1 MD 4300 C1 MD4300 C1 MD 4300C1 MD A20120128 A MDA20120128 A MD A20120128A MD 20120128 A MD20120128 A MD 20120128A MD 4300 C1 MD4300 C1 MD 4300C1
- Authority
- MD
- Moldova
- Prior art keywords
- liver cancer
- cell proliferation
- inhibitor
- hepg2 cell
- thiosemicarbazono
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to chemistry, namely to the synthesis of coordinative compounds from the class of thiosemicarbazonates of transition metals and can be used in medicine as cytostatic agent in the prophylaxis and treatment of liver cancer.Summary of the invention consists in the fact that as inhibitor of HepG2 cell proliferation in liver cancer is proposed the use of a new compound, chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel of formula:The claimed compound exhibits itself as an effective inhibitor of HepG2 cell proliferation in liver cancer at concentrations of 10-5…10-6 mol/L.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20120128A MD4300C1 (en) | 2012-12-28 | 2012-12-28 | Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20120128A MD4300C1 (en) | 2012-12-28 | 2012-12-28 | Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4300B1 MD4300B1 (en) | 2014-08-31 |
MD4300C1 true MD4300C1 (en) | 2015-03-31 |
Family
ID=51485231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20120128A MD4300C1 (en) | 2012-12-28 | 2012-12-28 | Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4300C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD4407C1 (en) * | 2015-04-29 | 2016-10-31 | Государственный Университет Молд0 | Inhibitor of human myeloid leukemia HL-60 cells based on bis[N-(prop-2-en-1-yl)-2-(pyridine-2-ylmethylidene)hydrazinecarbothioamide]nickel(II) chloride hydrate |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD891G2 (en) * | 1996-06-24 | 1998-07-31 | Николае ЕРЕМИЯ | Method for animals immunologic system potentiation remedy |
CN101205233A (en) * | 2007-12-14 | 2008-06-25 | 中国科学院南海海洋研究所 | Dimeric flavone compound as well as preparation and uses thereof |
CN101204401A (en) * | 2007-12-14 | 2008-06-25 | 中国科学院南海海洋研究所 | Sea hedgehog extractive, preparation method and anticancer application thereof |
CN101333236A (en) * | 2008-08-05 | 2008-12-31 | 浙江大学 | Method for preparing clitocine and applications in antineoplastic medicaments |
RU2008144584A (en) * | 2006-04-12 | 2010-05-20 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | 4,5-DIHYDRO- [1,2,4] TRIAZOLO [4,3-F] PERIDINES AS PLK1 PROTEINKINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
CN102038934A (en) * | 2005-11-03 | 2011-05-04 | 福建医科大学 | Application of cucurmosin in preparation of drug for treating breast cancer |
CN102219822A (en) * | 2011-03-24 | 2011-10-19 | 上海交通大学 | Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
-
2012
- 2012-12-28 MD MDA20120128A patent/MD4300C1/en not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD891G2 (en) * | 1996-06-24 | 1998-07-31 | Николае ЕРЕМИЯ | Method for animals immunologic system potentiation remedy |
CN102038934A (en) * | 2005-11-03 | 2011-05-04 | 福建医科大学 | Application of cucurmosin in preparation of drug for treating breast cancer |
RU2008144584A (en) * | 2006-04-12 | 2010-05-20 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | 4,5-DIHYDRO- [1,2,4] TRIAZOLO [4,3-F] PERIDINES AS PLK1 PROTEINKINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES |
CN101205233A (en) * | 2007-12-14 | 2008-06-25 | 中国科学院南海海洋研究所 | Dimeric flavone compound as well as preparation and uses thereof |
CN101204401A (en) * | 2007-12-14 | 2008-06-25 | 中国科学院南海海洋研究所 | Sea hedgehog extractive, preparation method and anticancer application thereof |
CN101333236A (en) * | 2008-08-05 | 2008-12-31 | 浙江大学 | Method for preparing clitocine and applications in antineoplastic medicaments |
CN102219822A (en) * | 2011-03-24 | 2011-10-19 | 上海交通大学 | Ganoderic acid T amide derivative TLTO-A and synthetic method and application thereof |
Non-Patent Citations (4)
Title |
---|
Mohammad M. Hassanien, Wael I. Mortada, Ali M. Hassan, Ahmed A. El-Asmy Synthesis, characterization and biological activities of 4-(p-chlorophenyl)-1-(pyridine-2-yl)thiosemicarbazibe and its metal complexes. Journal of the Korean Chemical Society, 2012, vol. 56. Nr. 6. p. 679 - 691 * |
Poma P., Notarbartolo M ., Labbozzetta M., Sanguedolce R., Alaimo A., Carina V., Maurici A., Cusimano A., Cervello M., D'Alessandro N. Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. 2006.04.28 Nr.4, p.923-30: <URL: <http://www.ncbi.nlm.nih.gov/pubmed/16525642>> * |
Qi Qin, Yi-Wei Lin, Xiang-Yi Zheng, Hong Chen, Qi-Qi Mao, Kai Yang, Shou-Jiang Huang, Zheng-Yan Zhao. RNAa-mediated overexpression of WT1 induces apoptosis in HepG2 cells. World Journal of Surgical Oncology 2012,10:11, p. 1-8 * |
Горбунова В. А. Новые цитостатики в лечении злокачественных опухолей. Медицина, 1998, 128с * |
Also Published As
Publication number | Publication date |
---|---|
MD4300B1 (en) | 2014-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500225A1 (en) | Novel quinoline-substituted compound | |
EA201690598A1 (en) | AMINOGETEROARIL BENZAMIDES AS KINASE INHIBITORS | |
MX2015002616A (en) | Synthesis of bis(fluorosulfonyl)imide. | |
MX350892B (en) | Synthesis of antiviral compound. | |
CR20200276A (en) | SULFAMOYLARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B (DIVISIONAL EXP. 2015-0059) | |
NZ716840A (en) | Combination formulation of two antiviral compounds | |
BR112014005226A2 (en) | benzonitrile derivatives as kinase inhibitors | |
EA201391822A1 (en) | NEW PYRIDINE DERIVATIVES | |
GEP201606532B (en) | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 | |
JO3025B1 (en) | Oxazole substituted indazoles as pi3 - kinase inhibitors | |
EA201490747A1 (en) | 1-Arylcarbonyl-4-oxypiperidine compounds useful for the treatment of neurodegenerative diseases | |
EA201390794A1 (en) | BICYCLIC COMPOUND | |
EA201590661A1 (en) | AZACHINASOLINE INHIBITORS OF ATYPICAL PROTEINKINASE C | |
CL2016000382A1 (en) | Processes to prepare antiviral compounds | |
TR201906413T4 (en) | Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide. | |
GEP201606598B (en) | Heteroaromatic compounds as dopamine d1 ligands | |
CR20150245A (en) | NEW PROCESS FOR THE PREPARATION OF COMPOUNDS FOR USE IN CANCER TREATMENT | |
MD4194B1 (en) | Trinuclear coordinative compound tris{µ-¢3,5-dibromo-2-hydroxybenzylidene-4′-(pyridin-2-yl)-thiosemicarbazido(2-)]copper}hydrate, exhibiting antifungal activity against Candida albicans | |
MX338885B (en) | Compounds useful in the synthesis of benzamide compounds. | |
MX2014004920A (en) | Novel pyrazine derivatives. | |
EA201591498A1 (en) | AZETIDINYLOXYPHENYLPYRROLIDINE COMPOUNDS | |
MX2015012318A (en) | Solid state forms of a quinazoline derivative and its use as a braf inhibitor. | |
IN2014DN10198A (en) | ||
EA201401277A1 (en) | METHANTION COMPOUNDS WITH ANTI-VIRUS ACTIVITY | |
MD4300C1 (en) | Inhibitor of HepG2 cell proliferation in liver cancer based on chloro-[2-phenyl(pyridine-2-yl)methanone-4-(3-methoxyphenyl)thiosemicarbazono]nickel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |